ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag microbiology policy disease medicine careers

us capitol stem politicians
A Year After the Midterm Elections, Where Are They Now?
Katarina Zimmer | Dec 17, 2019 | 6 min read
Political newcomers to federal and state legislatures with STEM backgrounds are bringing evidence to drafting laws, yet getting bills passed remains elusive.
Artist’s rendering of brain fog: a bright blue drawing of a brain sits inside of a pink drawing of a head in profile surrounded by miscellaneous shapes
Brain Fog Caused by Long COVID and Chemo Appear Similar
Dan Robitzski | Jan 28, 2022 | 6 min read
Data from mouse models for mild coronavirus infections and human tissue samples offer further evidence that it doesn’t take a severe infection—or even infection of brain cells at all—to cause long-term neurological symptoms.
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
Newly Elected Members Bring Diversity, Change To Institute Of Medicine
Edward Silverman | Nov 26, 1995 | 4 min read
Institute Of Medicine Author: Edward R. Silverman Sidebar: Members of the IOM With the election last month of its latest slate of members, the Institute of Medicine (IoM)-an honor society affiliated with the National Academy of Sciences-will have more women in its ranks than at any other time in its 25-year history when the honorees are inducted next year. Including the 15 women who are among the crop of 55 new members elected in October, women now constitute 21 percent of the society's 519 r
Family Membership Becomes Tradition At Institute Of Medicine
Edward Silverman | Feb 1, 1998 | 10+ min read
Membership in the Institute of Medicine (IoM) is becoming a family affair. Increasingly, members of the same family-husbands and wives, and also parents and their offspring-are being elected to the honor society. Six couples now boast membership. There also are four instances in which a parent and a son or daughter have been elected to the institute. And in one extraordinary case, there's a husband and wife and their daughter. "Perhaps both nature and nurture helped to shape the offspring," say
What Budget Cuts Might Mean for US Science
Diana Kwon | Mar 21, 2017 | 5 min read
A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  
Of Cells and Limits
Anna Azvolinsky | Mar 1, 2015 | 9 min read
Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
The Biotech Triangle
Ted Agres | Oct 28, 2001 | 6 min read
Editor's Note: This is the fourth and final installment this year of a series that focuses on regional hot spots in the United States John Hamer, a tenured professor of microbiology at Purdue University, decided he had reached the top of the academic career ladder three years ago and wanted more involvement in technology development. With the genomics and bioinformatics revolution under way, Hamer had his pick of companies and cities. But rather than relocating to an urban biotech center in Cal

Run a Search

ADVERTISEMENT